MarketWatch: Health Round-up
Pages: 59
Publisher: Datamonitor
Date Published: March 2006
Format: PDF
Price: $400
Overview
Datamonitor’s MarketWatch Health Round-up is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the Healthcare industry. The report contains the latest news, analysis and opinion, covering all the month’s major issues and events in R&D, regulatory and licensing in the Healthcare industry.
Table of Contents
In this month’s MarketWatch…
Pharmaceutical Company Round-up
Page 3
Cancer Update
Page 4 – News Round-up
Page 6 – Opinion: Cell Therapeutics: hoping for a rich performance…
Page 7 – Opinion: Xanthus: more hurdles to clear for Symadex…
Page 8 – Opinion: Genentech/Roche: trial delay won’t choke Avastin’s growth…
Page 8 – Opinion: Pfizer: Sutent gains double indication approval…
Cardiovascular Update
Page 10 – News Round-up
Page 12 – Opinion: Guidant: bidding war continues…
Page 12 – Opinion: AstraZeneca: Toprol ruling worsens generic woes…
Page 13 – Opinion: Sanofi-Aventis/BMS: a Plavix plague on both their houses?
Page 14 – Opinion: Sanofi-Aventis: strong sales before generics gloom…
Page 15 – Opinion: Bayer: cardiovascular concerns could run deep…
Page 16 – Opinion: Cardiovascular risk factors: unhealthy lifestyles could cost 10 years…
CNS Update
Page 17 – News Round-up
Page 19 – Opinion: Alzheimer’s disease: testing times for those at risk…
IDI Update
Page 20 – News Round-up
Page 22 – Opinion: Novartis: Prexige launches in the UK…
Page 22 – Opinion: Novo Nordisk/G2 Therapies: expanding operations…
Page 23 – Opinion: Dynavax: outlook good for allergy drug…
Page 25 – Feature Analysis: COPD: the silent killer…
Infectious Diseases Update
Page 27 – News Round-up
Page 29 – Opinion: Migenix: infectious ambitions in hepatitis…
Page 29 – Opinion: Chiron: rising from the ashes…
Page 30 – Opinion: Novartis: strengthening its infectious disease portfolio…
Page 31 – Opinion: Novartis/Idenix: entering hepatitis B market…
Page 32 – Feature Analysis: China: hepatitis treatment fails to keep pace with economy…
Company Spotlight
Page 35 – King Pharmaceuticals
Biotechnology Update
Page 42 – Biotech News Round-up
Page 45 – Feature Analysis: Biogenerics: the battle is only just beginning…
Page 47 – Feature Analysis: Can therapeutic vaccines fulfill their promise?
Company Spotlight
Page 50 – Gilead Sciences, Inc
Index
Page 58 – Pharma companies
Page 58 – Biotech companies
Page 59 – Key drugs
